Analgesic & Anti-inflammatory Tablet Franchise in Ahmedabad

Naproxen 550mg Tablet Supplier in Mumbai

Pain Relief Tablet Distributor in Delhi

Musculoskeletal Therapy Tablet Manufacturer in Bangalore

Anti-inflammatory Tablet Stockist in Hyderabad
Naproxen Tablet Exporter in Chandigarh

Home/Products /naproxen-500mg-tablet

Naprohike 550 Tablet

Composition : Naproxen (550mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Naprohike 550 Tablet contains Naproxen 550mg, a non-steroidal anti-inflammatory drug (NSAID) widely used to manage moderate to severe pain and inflammation associated with musculoskeletal conditions. It is particularly effective in arthritis, back pain, and post-operative pain management.

Naproxen works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, which decreases prostaglandin production, leading to reduced pain, inflammation, and swelling. Its sustained effect makes it suitable for once or twice daily dosing, providing consistent symptom control.

Clinically, Naprohike 550 Tablet is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendonitis, bursitis, and acute musculoskeletal injuries. The tablet formulation ensures accurate dosing, high bioavailability, and convenient administration, improving patient adherence.

Regular use under medical supervision helps in alleviating pain, reducing joint stiffness, and improving mobility, contributing to enhanced quality of life. Naprohike 550 Tablet is a trusted analgesic and anti-inflammatory therapy, offering reliable relief for patients with chronic or acute musculoskeletal conditions.

Read More

About the Product

Naprohike 550 Tablet contains Naproxen 550mg, a non-steroidal anti-inflammatory drug (NSAID) widely used to manage moderate to severe pain and inflammation associated with musculoskeletal conditions. It is particularly effective in arthritis, back pain, and post-operative pain management.

Naproxen works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, which decreases prostaglandin production, leading to reduced pain, inflammation, and swelling. Its sustained effect makes it suitable for once or twice daily dosing, providing consistent symptom control.

Clinically, Naprohike 550 Tablet is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendonitis, bursitis, and acute musculoskeletal injuries. The tablet formulation ensures accurate dosing, high bioavailability, and convenient administration, improving patient adherence.

Regular use under medical supervision helps in alleviating pain, reducing joint stiffness, and improving mobility, contributing to enhanced quality of life. Naprohike 550 Tablet is a trusted analgesic and anti-inflammatory therapy, offering reliable relief for patients with chronic or acute musculoskeletal conditions.

Common side effects may include stomach upset, nausea, heartburn, or mild dizziness. Rarely, gastrointestinal bleeding, allergic reactions, kidney impairment, or cardiovascular complications may occur with prolonged or high-dose use.

Naprohike 550 Tablet is indicated for the management of moderate to severe pain, inflammation, and swelling associated with arthritis, musculoskeletal injuries, and other inflammatory disorders, as advised by a physician.

For oral use only. Use strictly under medical supervision. Take with food or milk to minimize gastrointestinal discomfort. Inform your doctor if you have a history of stomach ulcers, kidney or liver disorders, or heart disease. Discontinue use and consult a physician if severe reactions occur.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the tablets tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation